(In the Media) “Study group for the suitable drug information” recommended pharmaceutical industry (the Nikkei Medical, the July 2016 edition）
date : 7/1/2016
An article featuring a “Round-table discussion among those with ‘Study group for the suitable drug information’ recommended pharmaceutical industry.’ in which Toshio Miyata, HGPI Board Member participated, appeared in the July 2016 edition of the Nikkei Medical.
This study group is organized by Nikkei Medical and the member are 5 are doctors. They take more regulation of providing drug information seriously.
In the last four meetings, they were talking about desirable drug information. And this time, they recommended the suitable drug information for the pharmaceutical industry.
Top Research & Recommendations Posts
- [Research Report] Energy Conservation and Greenhouse Gas Emissions Reduction in Healthcare Facilities: Case Studies from New Construction and Facility Renewal (March 16, 2026)
- [Public Comment Submission] “The 7th Science, Technology and Innovation Basic Plan” (Draft) (February 19, 2026)
- [Research Report] The 2026 Public Opinion Survey on Healthcare in Japan (February 13, 2026)
- [Research Report] The 2025 Public Opinion Survey on Healthcare in Japan (March 17, 2025)
- [Research Report] Perceptions, Knowledge, Actions and Perspectives of Healthcare Organizations in Japan in Relation to Climate Change and Health: A Cross-Sectional Study (November 13, 2025)
- [Policy Recommendations] Policy Recommendations in the Field of Blood Disorders “Building a Healthcare Ecosystem Centered on Patients and Those Affected” (April 13, 2026)
- [Policy Recommendations] Reshaping Japan’s Immunization Policy for Life Course Coverage and Vaccine Equity: Challenges and Prospects for an Era of Prevention and Health Promotion (April 25, 2025)
- [Policy Recommendations] Mental Health Project: Recommendations on Three Issues in the Area of Mental Health (July 4, 2025)
- [Policy Recommendations] Developing a National Health and Climate Strategy for Japan (June 26, 2024)
- [Public Comment Submission] R&D and Social Implementation Plan for “Achieving Carbon Neutrality in the Waste and Resource Circulation” under the Green Innovation Fund Projects (Draft Revision) (March 25, 2026)
Featured Posts
-
2026-02-13
[Research Report] The 2026 Public Opinion Survey on Healthcare in Japan (February 13, 2026)
![[Research Report] The 2026 Public Opinion Survey on Healthcare in Japan (February 13, 2026)](https://hgpi.org/en/wp-content/uploads/sites/2/HGPI_The2026PublicOpinionSurveyOnHealthcareInJapan_20260213.jpg)
-
2026-03-23
[Registration Open] Application for the Health Policy Academy the 15th Session (Session Starts July 2026)
![[Registration Open] Application for the Health Policy Academy the 15th Session (Session Starts July 2026)](https://hgpi.org/en/wp-content/uploads/sites/2/HGPI_20260319_HPA15.jpg)
-
2026-04-01
[Registration Open] (Webinar) The 143rd HGPI Seminar “20 Years Since the Enactment of the Cancer Control Act: Reflecting on the Past and Envisioning the Next 20 Years” (April 28, 2026)
![[Registration Open] (Webinar) The 143rd HGPI Seminar “20 Years Since the Enactment of the Cancer Control Act: Reflecting on the Past and Envisioning the Next 20 Years” (April 28, 2026)](https://hgpi.org/en/wp-content/uploads/sites/2/HGPI_20260428_143rd-HGPI-Seminar.png)
-
2026-04-15
[HGPI Policy Column] (No.70) — From the Planetary Health Project “Part 17: The Lancet Countdown: A ‘Lifeline’ for Health and Economy Brought about by Climate Action”
![[HGPI Policy Column] (No.70) — From the Planetary Health Project “Part 17: The Lancet Countdown: A ‘Lifeline’ for Health and Economy Brought about by Climate Action”](https://hgpi.org/en/wp-content/uploads/sites/2/HGPI_20260410_Lancet-Countdown-Column.png)
